Versican as a component of extracellular matrixplays a central role in inflammation and as a result it is emergingas a potential target in various inflammatory conditions [31].Therapeutic intervention to prevent or down regulate Versicanmay be of potential use in SCD also through halting theprogression of inflammation and blood coagulation. This evidence concerns the gene VCAN and Schnyder corneal dystrophy.